Literature DB >> 4057489

A neuroleptic malignantlike syndrome due to levodopa therapy withdrawal.

J H Friedman, S S Feinberg, R G Feldman.   

Abstract

Three cases of a syndrome resembling neuroleptic malignant syndrome are described in patients never exposed to neuroleptics. Each patient had a long history of Parkinson's disease treated with a carbidopa-levodopa combination. Two patients developed the syndrome when administration of the drug was discontinued temporarily. One developed the syndrome before the "drug holiday," and then died during the holiday because of this complication.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4057489

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  20 in total

1.  Case files of the program in medical toxicology at brown university: amantadine withdrawal and the neuroleptic malignant syndrome.

Authors:  Eric Brantley; Jamieson Cohn; Kavita Babu
Journal:  J Med Toxicol       Date:  2009-06

2.  Apomorphine in malignant syndrome due to levodopa withdrawal.

Authors:  U Bonuccelli; P Piccini; G U Corsini; A Muratorio
Journal:  Ital J Neurol Sci       Date:  1992-03

3.  A Complex Presentation of Pediatric Neuroleptic Malignant Syndrome Related to Polypharmacy in a 12-Year-Old Male.

Authors:  Nathaniel Sharon; Chandra Cullen; Kara Martinez
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-07-01       Impact factor: 2.576

Review 4.  Treatment of movement disorder emergencies.

Authors:  Steven J Frucht
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

5.  Levodopa withdrawal and the neuroleptic malignant syndrome.

Authors:  R Sandyk; R P Iacono
Journal:  Postgrad Med J       Date:  1986-07       Impact factor: 2.401

Review 6.  Clinical management of neuroleptic malignant syndrome.

Authors:  V L Susman
Journal:  Psychiatr Q       Date:  2001

Review 7.  Psychiatric aspects of Parkinson's disease--an update.

Authors:  Anette Schrag
Journal:  J Neurol       Date:  2004-07       Impact factor: 4.849

Review 8.  Movement disorder emergencies.

Authors:  Kathleen L Poston; Steven J Frucht
Journal:  J Neurol       Date:  2008-08       Impact factor: 4.849

9.  Hyperthermic syndromes and impairment of the dopaminergic system: a clinical study.

Authors:  L Figà-Talamanca; C Gualandi
Journal:  Ital J Neurol Sci       Date:  1989-02

10.  Neuroleptic malignant syndrome in an AIDS patient: clinical and pathological findings.

Authors:  A S Gabellini; A Pezzoli; P De Massis; G Casadei; A Grillo; T Sacquegna
Journal:  Ital J Neurol Sci       Date:  1994-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.